These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11893544)

  • 1. Cellular platforms for HTS: three case studies.
    Johnston PA; Johnston PA
    Drug Discov Today; 2002 Mar; 7(6):353-63. PubMed ID: 11893544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origin and evolution of high throughput screening.
    Pereira DA; Williams JA
    Br J Pharmacol; 2007 Sep; 152(1):53-61. PubMed ID: 17603542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the HTS paradigm.
    Inglese J
    Drug Discov Today; 2002 Sep; 7(18 Suppl):S105-6. PubMed ID: 12546874
    [No Abstract]   [Full Text] [Related]  

  • 4. High-throughput screening: update on practices and success.
    Fox S; Farr-Jones S; Sopchak L; Boggs A; Nicely HW; Khoury R; Biros M
    J Biomol Screen; 2006 Oct; 11(7):864-9. PubMed ID: 16973922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput cell analysis using multiplexed array technologies.
    Beske OE; Goldbard S
    Drug Discov Today; 2002 Sep; 7(18 Suppl):S131-5. PubMed ID: 12546879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II).
    Schröter T; Minond D; Weiser A; Dao C; Habel J; Spicer T; Chase P; Baillargeon P; Scampavia L; Schürer S; Chung C; Mader C; Southern M; Tsinoremas N; LoGrasso P; Hodder P
    J Biomol Screen; 2008 Jan; 13(1):17-28. PubMed ID: 18227223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Iterative Screening with Stepwise Compound Selection Based on Novartis In-house HTS Data.
    Paricharak S; IJzerman AP; Bender A; Nigsch F
    ACS Chem Biol; 2016 May; 11(5):1255-64. PubMed ID: 26878899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.
    Sukuru SC; Jenkins JL; Beckwith RE; Scheiber J; Bender A; Mikhailov D; Davies JW; Glick M
    J Biomol Screen; 2009 Jul; 14(6):690-9. PubMed ID: 19531667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity-based screening techniques for enhancing lead discovery.
    Comess KM; Schurdak ME
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Plate cherry picking": a novel semi-sequential screening paradigm for cheaper, faster, information-rich compound selection.
    Crisman TJ; Jenkins JL; Parker CN; Hill WA; Bender A; Deng Z; Nettles JH; Davies JW; Glick M
    J Biomol Screen; 2007 Apr; 12(3):320-7. PubMed ID: 17438067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Implementation of High-Throughput Screening Assays.
    Powell DJ; Hertzberg RP; Macarrόn R
    Methods Mol Biol; 2016; 1439():1-32. PubMed ID: 27316985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and implementation of high-throughput screening assays.
    Macarrón R; Hertzberg RP
    Methods Mol Biol; 2009; 565():1-32. PubMed ID: 19551355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current trends in high-throughput screening.
    Sterling J; Bojanic D; Eglen RM; Heyse S; Strulovici B
    Assay Drug Dev Technol; 2008 Aug; 6(4):491-504. PubMed ID: 18795872
    [No Abstract]   [Full Text] [Related]  

  • 15. Introduction: cell-based assays for high-throughput screening.
    An WF; Tolliday NJ
    Methods Mol Biol; 2009; 486():1-12. PubMed ID: 19347612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a facile method for high throughput screening with reporter gene assays.
    Goetz AS; Andrews JL; Littleton TR; Ignar DM
    J Biomol Screen; 2000 Oct; 5(5):377-84. PubMed ID: 11080697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of primary human cells in high-throughput screens.
    Dunne A; Jowett M; Rees S
    Methods Mol Biol; 2009; 565():239-57. PubMed ID: 19551366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpretation of uniform-well readouts.
    Josiah S
    Methods Mol Biol; 2009; 486():177-92. PubMed ID: 19347624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical drug metabolism in the age of high-throughput screening: an industrial perspective.
    Rodrigues AD
    Pharm Res; 1997 Nov; 14(11):1504-10. PubMed ID: 9434267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model.
    Kunz-Schughart LA; Freyer JP; Hofstaedter F; Ebner R
    J Biomol Screen; 2004 Jun; 9(4):273-85. PubMed ID: 15191644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.